D-0544-2018 Class II Terminated

Recalled by Apace KY LLC — Fountain Run, KY

FDA drug recall D-0544-2018 was initiated by Apace KY LLC on Feb 9, 2018 and is designated Class II. Reason for recall: Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities. The recall status is terminated (terminated Sep 10, 2019). Affected quantity: 630 cartons.

Recall details

Product Type
Drugs
Report Date
Mar 7, 2018
Initiation Date
Feb 9, 2018
Termination Date
Sep 10, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
630 cartons

Product description

Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478

Reason for recall

Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.

Distribution pattern

Nationwide

Code information

Lot: 19900, exp 05/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0544-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0544-2018. Report a data issue: hello@regdatalab.com.